Assertion list
trial (primary) → CapableOf

Results from Ascent++: 357
trialCapableOf enrol patient 0.68
trialCapableOf evaluate efficacy 0.67
trialCapableOf begin 0.65
trialCapableOf start with a fixation cross 0.61
trialCapableOf show significant reduction 0.61
trialCapableOf enrol participant 0.57
trialCapableOf meet criterion 0.57
trialCapableOf test our faith 0.56
trialCapableOf evaluate intervention 0.56
trialCapableOf show increase 0.56
trialCapableOf involve the participation of hu… 0.55
trialCapableOf report result 0.55
trialCapableOf investigate safety 0.55
trialCapableOf involve people 0.54
trialCapableOf run for six months 0.54
trialCapableOf provide datum 0.54
trialCapableOf follow controlled protocol 0.54
trialCapableOf report reduction 0.54
trialCapableOf last three weeks 0.54
trialCapableOf look at drug 0.53
trialCapableOf report mortality 0.53
trialCapableOf take place in the united states 0.53
trialCapableOf investigate patient 0.53
trialCapableOf take place in the uk 0.53
trialCapableOf compare reboxetine 0.53
trialCapableOf meet eligibility criteria 0.53
trialCapableOf show trend 0.53
trialCapableOf start with a fixation point 0.53
trialCapableOf raise question 0.52
trialCapableOf evaluate tolerability 0.52
trialCapableOf originate in china 0.52
trialCapableOf show similar results 0.52
trialCapableOf provide opportunity 0.52
trialCapableOf involve child 0.52
trialCapableOf report datum 0.52
trialCapableOf take 2-3 days 0.52
trialCapableOf pave the way 0.52
trialCapableOf show significant improvement 0.51
trialCapableOf originate in hong kong 0.51
trialCapableOf originate in japan 0.51
trialCapableOf produce evidence 0.51
trialCapableOf receive support 0.51
trialCapableOf start in 2006 0.51
trialCapableOf target patient 0.51
trialCapableOf recruit patient 0.51
trialCapableOf meet the inclusion criteria 0.50
trialCapableOf take month 0.50
trialCapableOf test new treatments 0.50
trialCapableOf begin in june 0.50
trialCapableOf examine the effect 0.50
trialCapableOf begin in september 0.50
trialCapableOf treat patient 0.50
trialCapableOf show benefit 0.50
trialCapableOf begin on march 0.50
trialCapableOf recruit participant 0.49
trialCapableOf last two weeks 0.49
trialCapableOf begin in october 0.49
trialCapableOf involve hundreds of patients 0.49
trialCapableOf begin in january 0.49
trialCapableOf satisfy normal requirements 0.49
trialCapableOf get closer 0.49
trialCapableOf begin in november 0.49
trialCapableOf provide information 0.49
trialCapableOf last for year 0.48
trialCapableOf show reduction 0.48
trialCapableOf enroll small number of patients 0.48
trialCapableOf begin on february 0.48
trialCapableOf begin in may 0.48
trialCapableOf begin with opening statements 0.48
trialCapableOf begin in april 0.48
trialCapableOf begin on monday 0.48
trialCapableOf evaluate pharmacokinetic 0.48
trialCapableOf show positive results 0.48
trialCapableOf end in mistrial 0.48
trialCapableOf last for month 0.47
trialCapableOf take place in europe 0.47
trialCapableOf find significant difference 0.47
trialCapableOf begin in july 0.47
trialCapableOf provide important information 0.47
trialCapableOf look at five major classes of d… 0.47
trialCapableOf report significant results 0.47
trialCapableOf take place in india 0.47
trialCapableOf take year 0.47
trialCapableOf remain unpublished 0.47
trialCapableOf provide evidence 0.47
trialCapableOf last several days 0.47
trialCapableOf begin in december 0.46
trialCapableOf test vaccine 0.46
trialCapableOf take place in chile 0.46
trialCapableOf begin on august 0.46
trialCapableOf shed light 0.46
trialCapableOf come into our lives 0.46
trialCapableOf focus on patient 0.46
trialCapableOf evaluate the safety 0.46
trialCapableOf use surrogate endpoints 0.45
trialCapableOf last two to three weeks 0.45
trialCapableOf strengthen our faith 0.45
trialCapableOf collect datum 0.45
trialCapableOf get under way 0.45
trialCapableOf compare new treatment 0.45
trialCapableOf cost money 0.45
trialCapableOf consist of two phases 0.44
trialCapableOf take week 0.44
trialCapableOf take day 0.43
trialCapableOf come our way 0.43
trialCapableOf end in december 0.43
trialCapableOf demonstrate the feasibility 0.42
trialCapableOf report negative results 0.42
trialCapableOf start in 2015 0.42
trialCapableOf assess pharmacodynamic 0.42
trialCapableOf save time 0.42
trialCapableOf end in november 0.42
trialCapableOf end in hung jury 0.41
trialCapableOf provide insight 0.41
trialCapableOf test the hypothesis 0.41
trialCapableOf use biomarker 0.41
trialCapableOf show decrease 0.41
trialCapableOf begin with jury selection 0.41
trialCapableOf end in june 0.41
trialCapableOf begin on tuesday 0.41
trialCapableOf resume on monday 0.41
trialCapableOf assess chelation therapy 0.40
trialCapableOf come to close 0.40
trialCapableOf occur on other hand 0.40
trialCapableOf take several years 0.40
trialCapableOf test tolerability 0.40
trialCapableOf show positive effect 0.40
trialCapableOf end with verdict 0.40
trialCapableOf take time 0.40
trialCapableOf fail to show benefit 0.40
trialCapableOf answer question 0.40
trialCapableOf consist of two parts 0.40
trialCapableOf look at the impact 0.40
trialCapableOf take place in november 0.40
trialCapableOf begin enrolling patient 0.39
trialCapableOf confirm result 0.39
trialCapableOf assess mortality 0.39
trialCapableOf begin in 2017 0.39
trialCapableOf begin in mid 0.39
trialCapableOf begin on oct. 0.39
trialCapableOf last six weeks 0.39
trialCapableOf last two years 0.39
trialCapableOf study the side effects 0.39
trialCapableOf confirm finding 0.38
trialCapableOf last several months 0.38
trialCapableOf begin in 2009 0.38
trialCapableOf enroll 12 patients 0.38
trialCapableOf run for two years 0.38
trialCapableOf begin in early 2016 0.38
trialCapableOf end on march 0.38
trialCapableOf end on september 0.38
trialCapableOf last four weeks 0.38
trialCapableOf assess improvement 0.37
trialCapableOf end in conviction 0.37
trialCapableOf end in hung juries 0.37
trialCapableOf set precedent 0.37
trialCapableOf take place in december 0.37
trialCapableOf continue on monday 0.37
trialCapableOf end in february 0.37
trialCapableOf end in january 0.37
trialCapableOf end in october 0.37
trialCapableOf evaluate preliminary efficacy 0.37
trialCapableOf find significant effect 0.37
trialCapableOf gain experience 0.37
trialCapableOf last three months 0.37
trialCapableOf lay the groundwork 0.37
trialCapableOf mark first time 0.37
trialCapableOf run through october 0.37
trialCapableOf accrue patient 0.36
trialCapableOf end in april 0.36
trialCapableOf provide answer 0.36
trialCapableOf start in 2014 0.36
trialCapableOf involve thousands of participan… 0.36
trialCapableOf begin in federal court 0.36
trialCapableOf begin on jan. 0.36
trialCapableOf continue to next stage 0.36
trialCapableOf gather information 0.36
trialCapableOf run until june 0.36
trialCapableOf sit without jury 0.36
trialCapableOf last 14 days 0.36
trialCapableOf proceed to conclusion 0.36
trialCapableOf begin on friday 0.36
trialCapableOf end in may 0.36
trialCapableOf end with guilty verdict 0.36
trialCapableOf enrol only patients 0.36
trialCapableOf evaluate the relationship 0.36
trialCapableOf focus on safety 0.36
trialCapableOf gather additional information 0.36
trialCapableOf last four months 0.36
trialCapableOf start on wednesday 0.36
trialCapableOf begin in 2007 0.35
trialCapableOf come in question 0.35
trialCapableOf continue for week 0.35
trialCapableOf draw to close 0.35
trialCapableOf generate datum 0.35
trialCapableOf provide the basis 0.35
trialCapableOf involve wrongful death 0.35
trialCapableOf apply to decision 0.34
trialCapableOf begin in 2010 0.34
trialCapableOf compare varenicline 0.34
trialCapableOf compared ertapenem 0.34
trialCapableOf determine damage 0.34
trialCapableOf end on july 0.34
trialCapableOf enrol 182 patients 0.34
trialCapableOf involve two trials 0.34
trialCapableOf last for approximately 18 months 0.34
trialCapableOf last several weeks 0.34
trialCapableOf provide sufficient data 0.34
trialCapableOf resume in january 0.34
trialCapableOf run for three months 0.34
trialCapableOf set the stage 0.34
trialCapableOf start in europe 0.34
trialCapableOf use cross-over design 0.34
trialCapableOf last week 0.34
trialCapableOf begin in 2013 0.34
trialCapableOf begin in 2018 0.34
trialCapableOf combine pembrolizumab 0.34
trialCapableOf compared azithromycin 0.34
trialCapableOf conclude on august 0.34
trialCapableOf focus on smoker 0.34
trialCapableOf involve 658 adults 0.34
trialCapableOf last until june 0.34
trialCapableOf measure effectiveness 0.34
trialCapableOf open on monday 0.34
trialCapableOf report clinical outcomes 0.34
trialCapableOf run until november 0.34
trialCapableOf start in 2012 0.34
trialCapableOf test the feasibility 0.34
trialCapableOf assess risk 0.33
trialCapableOf begin in the uk 0.33
trialCapableOf compare radiotherapy 0.33
trialCapableOf continue on thursday 0.33
trialCapableOf involve 30 patients 0.33
trialCapableOf last 10 weeks 0.33
trialCapableOf last five days 0.33
trialCapableOf last two months 0.33
trialCapableOf last until august 0.33
trialCapableOf run for 12 months 0.33
trialCapableOf take place in spain 0.33
trialCapableOf vary in length 0.33
trialCapableOf enroll small numbers of people 0.33
trialCapableOf address the question 0.33
trialCapableOf confirm efficacy 0.33
trialCapableOf achieve statistical significance 0.32
trialCapableOf aim to assess safety 0.32
trialCapableOf assess head injury events 0.32
trialCapableOf assess the impact of itns 0.32
trialCapableOf assess the nature of tackles 0.32
trialCapableOf be a feasibility study 0.32
trialCapableOf begin in 2008 0.32
trialCapableOf begin with central fixation 0.32
trialCapableOf begin with central fixation cro… 0.32
trialCapableOf come at time 0.32
trialCapableOf commence within 365 days 0.32
trialCapableOf draw attention 0.32
trialCapableOf evaluate cost-effectiveness 0.32
trialCapableOf involve money-laundering charges 0.32
trialCapableOf meet our selection criteria 0.32
trialCapableOf provide further data 0.32
trialCapableOf run to april 0.32
trialCapableOf take many forms 0.32
trialCapableOf test the effectiveness of inter… 0.32
trialCapableOf test the technology 0.32
trialCapableOf use innovative design 0.32
trialCapableOf report quality of life 0.32
trialCapableOf go on for long time 0.32
trialCapableOf give hope 0.32
trialCapableOf answer important questions 0.32
trialCapableOf apply to ehc plans 0.32
trialCapableOf assess anti-tumor activity 0.32
trialCapableOf begin in 2001 0.32
trialCapableOf begin in buenos aires 0.32
trialCapableOf bring closure 0.32
trialCapableOf collect pharmacokinetic data 0.32
trialCapableOf compare different doses 0.32
trialCapableOf continue through hemlock 0.32
trialCapableOf continue through rhododendron 0.32
trialCapableOf continue to recruit participant 0.32
trialCapableOf end on friday 0.32
trialCapableOf find clear differences 0.32
trialCapableOf find procedure 0.32
trialCapableOf involve 435 children 0.32
trialCapableOf involve more people 0.32
trialCapableOf last a few hours 0.32
trialCapableOf move to second phase 0.32
trialCapableOf open in april 0.32
trialCapableOf remain in abeyance 0.32
trialCapableOf remain open 0.32
trialCapableOf resume on june 0.32
trialCapableOf serve the ends of justice 0.32
trialCapableOf start in australia 0.32
trialCapableOf start in hungary 0.32
trialCapableOf start on thursday 0.32
trialCapableOf take place in coventry 0.32
trialCapableOf take place in tanzania 0.32
trialCapableOf take statin 0.32
trialCapableOf test the vaccine’s safety 0.32
trialCapableOf proceed 0.31
trialCapableOf assess qol 0.31
trialCapableOf begin before the end of the year 0.31
trialCapableOf begin in 2003 0.31
trialCapableOf begin in london 0.31
trialCapableOf continue before mr justice tony… 0.31
trialCapableOf continue for day 0.31
trialCapableOf determine liability 0.31
trialCapableOf estimate child's physical activ… 0.31
trialCapableOf focus on efficacy 0.31
trialCapableOf involve 14 patients 0.31
trialCapableOf involve personal injury 0.31
trialCapableOf involve uma bharti 0.31
trialCapableOf last four to six weeks 0.31
trialCapableOf open on june 0.31
trialCapableOf proceed with new members 0.31
trialCapableOf take place in milton keynes 0.31
trialCapableOf report adverse events 0.30
trialCapableOf exclude people 0.30
trialCapableOf find difference 0.30
trialCapableOf decide the facts of the case 0.29
trialCapableOf play critical role 0.29
trialCapableOf build character 0.28
trialCapableOf be a travesty of justice 0.28
trialCapableOf show significant benefit 0.27
trialCapableOf open the door 0.27
trialCapableOf produce result 0.27
trialCapableOf report improvement 0.27
trialCapableOf save money 0.27
trialCapableOf provide strong evidence 0.26
trialCapableOf take place in australia 0.26
trialCapableOf be a turning point 0.26
trialCapableOf drag on for year 0.26
trialCapableOf get used to get a number of mes… 0.26
trialCapableOf drag on for month 0.25
trialCapableOf explore the potential 0.25
trialCapableOf sentenced to death 0.25
trialCapableOf fail to meet international stan… 0.24
trialCapableOf look promising 0.24
trialCapableOf never took place 0.24
trialCapableOf provide valuable insight 0.24
trialCapableOf raise serious concerns 0.24
trialCapableOf show conflicting results 0.24
trialCapableOf support the research 0.24
trialCapableOf show promising results 0.24
trialCapableOf get used to the platform 0.24
trialCapableOf show promise 0.23
trialCapableOf fail to justify guantánamo tria… 0.23
trialCapableOf show modest improvement 0.23
trialCapableOf determine innocence 0.22
trialCapableOf cost millions of dollars 0.22
trialCapableOf end in deadlocked jury 0.22
trialCapableOf find significant association 0.22
trialCapableOf offer chance 0.22
trialCapableOf prove popular 0.22
trialCapableOf seem certain to fail 0.22
trialCapableOf show a survival benefit 0.22
trialCapableOf violate the constitution 0.22
trialCapableOf determine guilt 0.22
trialCapableOf report difference 0.15